Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

被引:0
|
作者
Grobben, Marloes [1 ]
van der Straten, Karlijn [1 ]
Brouwer, Philip J. M. [1 ]
Brinkkemper, Mitch [1 ]
Maisonnasse, Pauline [2 ]
Dereuddre-Bosquet, Nathalie [2 ]
Appelman, Brent [1 ]
Lovell, A. H. Ayesha [1 ]
van Vught, Lonneke A. [3 ]
Burger, Judith A. [1 ]
Poniman, Meliawati [1 ]
Oomen, Melissa [1 ]
Eggink, Dirk [4 ]
Bijl, Tom P. L. [1 ]
van Willigen, Hugo D. G. [1 ]
Wynberg, Elke [5 ]
Verkaik, Bas J. [1 ]
Figaroa, Orlane J. A. [1 ]
de Vries, Peter J. [6 ]
Boertien, Tessel M. [6 ]
Bomers, Marije K. [1 ]
Sikkens, Jonne J. [1 ]
Le Grand, Roger [7 ]
de Jong, Menno D. [8 ]
Prins, Maria [2 ]
Chung, Amy W. [9 ]
de Bree, Godelieve J. [1 ]
Sanders, Rogier W. [1 ]
van Gils, Marit J. [1 ]
机构
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Ctr Immunol Viral Autoimmune Hematol & Bacterial, Fontenay Aux Roses, France
[3] AMC, Ctr Expt Mol Med, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands
[5] Publ Hlth Serv Amsterdam GGD, Amsterdam, Netherlands
[6] Tergooi Hosp, Amsterdam, Netherlands
[7] Univ Paris, Paris, France
[8] Amsterdam Univ Med Ctr, Dept Med Microbiol & Infect Prevent, Amsterdam, Netherlands
[9] Univ Melbourne, Melbourne, Vic, Australia
来源
ELIFE | 2021年 / 10卷
基金
英国医学研究理事会;
关键词
antibodies; SARS-CoV-2; coronavirus; cross-reactivity; vaccine; COVID-19; Human; Other; SPIKE; CORONAVIRUSES; RESPONSES;
D O I
10.7554/eLife.70330; 10.7554/eLife.70330.sa0; 10.7554/eLife.70330.sa1; 10.7554/eLife.70330.sa2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not protect against future novel coronavirus outbreaks, emphasizing the need for more broadly protective vaccines. To inform the development of a pan-coronavirus vaccine, we investigated the presence and specificity of cross-reactive antibodies against the spike (S) proteins of human coronaviruses (hCoV) after SARS-CoV-2 infection and vaccination. We found an 11- to 123-fold increase in antibodies binding to SARS-CoV and MERS-CoV as well as a 2- to 4-fold difference in antibodies binding to seasonal hCoVs in COVID-19 convalescent sera compared to pre-pandemic healthy donors, with the S2 subdomain of the S protein being the main target for cross-reactivity. In addition, we detected cross-reactive antibodies to all hCoV S proteins after SARS-CoV-2 vaccination in macaques and humans, with higher responses for hCoV more closely related to SARS-CoV-2. These findings support the feasibility of and provide guidance for development of a pan-coronavirus vaccine.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
    Geanes, Eric S.
    LeMaster, Cas
    Fraley, Elizabeth R.
    Khanal, Santosh
    McLennan, Rebecca
    Grundberg, Elin
    Selvarangan, Rangaraj
    Bradley, Todd
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
    Eric S. Geanes
    Cas LeMaster
    Elizabeth R. Fraley
    Santosh Khanal
    Rebecca McLennan
    Elin Grundberg
    Rangaraj Selvarangan
    Todd Bradley
    Scientific Reports, 12
  • [3] Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
    Crowley, Andrew R.
    Natarajan, Harini
    Hederman, Andrew P.
    Bobak, Carly A.
    Weiner, Joshua A.
    Wieland-Alter, Wendy
    Lee, Jiwon
    Bloch, Evan M.
    Tobian, Aaron A. R.
    Redd, Andrew D.
    Blankson, Joel N.
    Wolf, Dana
    Goetghebuer, Tessa
    Marchant, Arnaud
    Connor, Ruth, I
    Wright, Peter F.
    Ackerman, Margaret E.
    ELIFE, 2022, 11
  • [4] Cross-Reactive Antibody Responses to Coronaviruses Elicited by SARS-CoV-2 Infection or Vaccination
    Lee, Richard S. H.
    Cheng, Samuel M. S.
    Zhao, Jin
    Tsoi, Annie Y. S.
    Lau, Kaman K. M.
    Chan, CoCo H. C.
    Li, John K. C.
    Hui, David S. C.
    Peiris, Malik
    Yen, Hui-Ling
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (05)
  • [5] Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
    Sarah Lapidus
    Feimei Liu
    Arnau Casanovas-Massana
    Yile Dai
    John D. Huck
    Carolina Lucas
    Jon Klein
    Renata B. Filler
    Madison S. Strine
    Mouhamad Sy
    Awa B. Deme
    Aida S. Badiane
    Baba Dieye
    Ibrahima Mbaye Ndiaye
    Younous Diedhiou
    Amadou Moctar Mbaye
    Cheikh Tidiane Diagne
    Inés Vigan-Womas
    Alassane Mbengue
    Bacary D. Sadio
    Moussa M. Diagne
    Adam J. Moore
    Khadidiatou Mangou
    Fatoumata Diallo
    Seynabou D. Sene
    Mariama N. Pouye
    Rokhaya Faye
    Babacar Diouf
    Nivison Nery
    Federico Costa
    Mitermayer G. Reis
    M. Catherine Muenker
    Daniel Z. Hodson
    Yannick Mbarga
    Ben Z. Katz
    Jason R. Andrews
    Melissa Campbell
    Ariktha Srivathsan
    Kathy Kamath
    Elisabeth Baum-Jones
    Ousmane Faye
    Amadou Alpha Sall
    Juan Carlos Quintero Vélez
    Michael Cappello
    Michael Wilson
    Choukri Ben-Mamoun
    Richard Tedder
    Myra McClure
    Peter Cherepanov
    Fabrice A. Somé
    Scientific Reports, 12
  • [6] Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
    Lapidus, Sarah
    Liu, Feimei
    Casanovas-Massana, Arnau
    Dai, Yile
    Huck, John D.
    Lucas, Carolina
    Klein, Jon
    Filler, Renata B.
    Strine, Madison S.
    Sy, Mouhamad
    Deme, Awa B.
    Badiane, Aida S.
    Dieye, Baba
    Ndiaye, Ibrahima Mbaye
    Diedhiou, Younous
    Mbaye, Amadou Moctar
    Diagne, Cheikh Tidiane
    Vigan-Womas, Ines
    Mbengue, Alassane
    Sadio, Bacary D.
    Diagne, Moussa M.
    Moore, Adam J.
    Mangou, Khadidiatou
    Diallo, Fatoumata
    Sene, Seynabou D.
    Pouye, Mariama N.
    Faye, Rokhaya
    Diouf, Babacar
    Nery, Nivison
    Costa, Federico
    Reis, Mitermayer G.
    Muenker, M. Catherine
    Hodson, Daniel Z.
    Mbarga, Yannick
    Katz, Ben Z.
    Andrews, Jason R.
    Campbell, Melissa
    Srivathsan, Ariktha
    Kamath, Kathy
    Baum-Jones, Elisabeth
    Faye, Ousmane
    Sall, Amadou Alpha
    Velez, Juan Carlos Quintero
    Cappello, Michael
    Wilson, Michael
    Ben-Mamoun, Choukri
    Tedder, Richard
    McClure, Myra
    Cherepanov, Peter
    Some, Fabrice A.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] Cross-reactive memory T cells abort SARS-CoV-2 infection
    Flemming A.
    Nature Reviews Immunology, 2022, 22 (1) : 5 - 5
  • [8] SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
    Reincke, S. Momsen
    Yuan, Meng
    Kornau, Hans-Christian
    Corman, Victor M.
    van Hoof, Scott
    Sanchez-Sendin, Elisa
    Ramberger, Melanie
    Yu, Wenli
    Hua, Yuanzi
    Tien, Henry
    Schmidt, Marie Luisa
    Schwarz, Tatjana
    Jeworowski, Lara Maria
    Brandl, Sarah E.
    Rasmussen, Helle Foverskov
    Homeyer, Marie A.
    Stoffler, Laura
    Barner, Martin
    Kunkel, Desiree
    Huo, Shufan
    Horler, Johannes
    von Wardenburg, Niels
    Kroidl, Inge
    Eser, Tabea M.
    Wieser, Andreas
    Geldmacher, Christof
    Hoelscher, Michael
    Ganzer, Hannes
    Weiss, Gunter
    Schmitz, Dietmar
    Drosten, Christian
    Pruss, Harald
    Wilson, Ian A.
    Kreye, Jakob
    SCIENCE, 2022, 375 (6582) : 782 - +
  • [9] Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
    Edara, Venkata Viswanadh
    Hudson, William H.
    Xie, Xuping
    Ahmed, Rafi
    Suthar, Mehul S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (18): : 1896 - 1898
  • [10] Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
    Ljung, Rickard
    Pihlstrom, Nicklas
    Sundstrom, Anders
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : 775 - 776